Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC von Santoro, Armando, Pilar, Garrido, Tan, Daniel S W, Zugazagoitia, Jon, Shepherd, Frances A, Bearz, Alessandra, Barlesi, Fabrice, Kim, Tae Min, Overbeck, Tobias R, Felip, Enriqueta, Cai, Can, Simantini, Eddy, McCulloch, Tracey, Schaefer, Eric S

Volltext

Correction: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC von Santoro, Armando, Pilar, Garrido, Tan, Daniel S W, Zugazagoitia, Jon, Shepherd, Frances A, Bearz, Alessandra, Barlesi, Fabrice, Kim, Tae Min, Overbeck, Tobias R, Felip, Enriqueta, Cai, Can, Eddy, Simantini, McCulloch, Tracey, Schaefer, Eric S

Volltext

Bioavailability of everolimus administered as a single 5 mg tablet versus five 1 mg tablets: a randomized, open-label, two-way crossover study of healthy volunteers von Thudium, Karen, Gallo, Jorge, Bouillaud, Emmanuel, Sachs, Carolin, Eddy, Simantini, Cheung, Wing

Volltext

Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms von Yao, James C, Strosberg, Jonathan, Fazio, Nicola, Pavel, Marianne E, Bergsland, Emily, Ruszniewski, Philippe, Halperin, Daniel M, Li, Daneng, Tafuto, Salvatore, Raj, Nitya, Campana, Davide, Hijioka, Susumu, Raderer, Markus, Guimbaud, Rosine, Gajate, Pablo, Pusceddu, Sara, Reising, Albert, Degtyarev, Evgeny, Shilkrut, Mark, Eddy, Simantini, Singh, Simron

Volltext

Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies von Stein, Mark, Lin, Hongxia, Jeyamohan, Chandrika, Dvorzhinski, Dmitri, Gounder, Murugesan, Bray, Kevin, Eddy, Simantini, Goodin, Susan, White, Eileen, DiPaola, Robert S.

Volltext

Phase 1 dose‐escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma von Rini, Brian I., Stein, Mark, Shannon, Pat, Eddy, Simantini, Tyler, Allison, Stephenson, Joe J., Catlett, Lorie, Huang, Bo, Healey, Diane, Gordon, Michael

Volltext

Transdermal estradiol in castrate and chemotherapy resistant prostate cancer von Stein, Mark, Goodin, Susan, Doyle-Lindrud, Susan, Silberberg, Jeffery, Kane, Michael, Metzger, Dorinda, Eddy, Simantini, Shih, Weichung, DiPaola, Robert S

Volltext

TargetingTumor MetabolismWith 2-Deoxyglucose in Patients With Castrate-Resistant Prostate Cancer and Advanced Malignancies von Stein, Mark, Lin, Hongxia, Jeyamohan, Chandrika, Dvorzhinski, Dmitri, Gounder, Murugesan, Bray, Kevin, Eddy, Simantini, Goodin, Susan, White, Eileen, DiPaola, Robert S.

Volltext

A Multi-institutional Phase 2 Study of Imatinib Mesylate and Gemcitabine for First-Line Treatment of Advanced Pancreatic Cancer von Moss, Rebecca A, Moore, Dirk, Mulcahy, Mary F, Nahum, Kenneth, Saraiya, Biren, Eddy, Simantini, Kleber, Martin, Poplin, Elizabeth A

Volltext